243
Participants
Start Date
September 8, 2023
Primary Completion Date
June 13, 2024
Study Completion Date
February 14, 2025
INV-202
tablet, once daily, oral
Placebo
tablet, once daily, oral
Office of David H. Shu, MD, New Westminster
Centricity Research -New Minas, New Minas
Aggarwal and Associates, Limited, Brampton
Wharton Medical Clinic (WMC) - Toronto, Hamilton
Milestone Research Inc, London
Diex Recherche Trois-Rivieres, Trois-Rivières
Centricity Research - Oshawa, Oshawa
Bluewater Clinical Research Group Inc, Sarnia
Canadian Phase Onward Inc., Toronto
Dr. Anil K. Gupta Medicine Professional Corporation, Toronto
Dr. Sameh Fikry Medicine Professional Corporation, Waterloo
Clinical Research Solutions, Waterloo
Ecogene-21, Chicoutimi
DIEX Research Joliette, Joliette
Centricity Research - Levis, Lévis
Centricity Research - Mirabel, Mirabel
9109-0126 Quebec Inc, Montreal
Centricity Research - Pointe-Claire, Pointe-Claire
DIEX Research Quebec, Québec
Centre des maladies lipidique deq Quebec, CMLQ Inc., Québec
Alpha Recherche Clinique - Lebourgneuf, Québec
Alpha Recherche Clinique Val-Bélair, Québec
Diex Recherche Sherbrooke, Sherbrooke
Diex Recherche Victoriaville, Victoriaville
Lead Sponsor
Inversago Pharma Inc.
INDUSTRY